Bioscience Methods 2024, Vol.15, No.4, 162-172 http://bioscipublisher.com/index.php/bm 1 70 7 Challenges and Future Directions 7.1 Technical challenges in achieving comprehensive pathogen elimination Achieving comprehensive pathogen elimination in genetically modified pigs for xenotransplantation presents several technical challenges. One significant hurdle is the elimination of porcine endogenous retroviruses (PERVs), which pose a risk of cross-species transmission. Although recent advancements have enabled the inactivation of PERVs using CRISPR-Cas9 technology, ensuring complete and stable elimination remains complex. Additionally, the genetic modification process itself can introduce unintended mutations or off-target effects, complicating the pathogen elimination efforts (Li et al., 2021). Another challenge is the need to disrupt multiple genes responsible for xenoantigens, such as αGal, Neu5Gc, and Sda, which are known to provoke immune responses in humans. The sequential disruption of these genes requires precise and efficient gene-editing techniques to avoid compromising the viability and functionality of the pig organs (Deng, 2022). 7.2 Long-term stability and potential off-target effects of genetic modifications The long-term stability of genetic modifications in pigs is crucial for the success of xenotransplantation. One concern is the potential for genetic modifications to revert or lose efficacy over time, which could lead to the re-emergence of pathogens or xenoantigens. Ensuring the stable transmission of these modifications across generations is essential, as demonstrated by studies showing normal physiology and fertility in genetically engineered pigs (Kemter et al., 2018). However, the potential off-target effects of gene-editing technologies, such as CRISPR-Cas9, remain a significant concern. These off-target effects can lead to unintended genetic changes that may affect the health and safety of the modified pigs and the recipients of their organs (Li et al., 2021). Continuous monitoring and refinement of gene-editing techniques are necessary to minimize these risks and ensure the long-term success of xenotransplantation. 7.3 Future research directions and potential breakthroughs in biosafety enhancement Future research in the field of xenotransplantation should focus on several key areas to enhance biosafety. One promising direction is the development of more sophisticated gene-editing tools that offer higher precision and fewer off-target effects, thereby improving the safety and efficacy of genetic modifications. Additionally, research should explore the combination of genetic modifications with advanced immunosuppressive therapies to further reduce the risk of immune rejection and improve graft survival (Sykes and Sachs, 2019). Another potential breakthrough lies in the comprehensive characterization and elimination of all potential pathogens, including those not yet identified, through advanced genomic and proteomic techniques49. Finally, the establishment of robust in vitro and in vivo models to evaluate the safety and efficacy of genetically modified pig organs before clinical trials will be crucial in accelerating the translation of xenotransplantation into clinical practice (Lei et al., 2022). By addressing these challenges and pursuing these research directions, the field of xenotransplantation can move closer to providing a reliable and safe solution to the organ shortage crisis. 8 Concluding Remarks The research on genetic modifications in pigs for xenotransplantation has shown significant progress in addressing the immunological barriers and potential zoonotic risks associated with the procedure. The use of CRISPR/Cas9 technology to modify specific porcine genes such as GGTA1, CMAH, β4GalNT2, vWF, and ASGR1 has demonstrated efficiency in preventing xenograft rejection by human recipients1. Additionally, the off-target effects of these genetic modifications have been assessed, ensuring the precision and safety of the genetic alterations (Ryczek et al., 2020). Another critical finding is the impact of porcine cytomegalovirus (PCMV) on the survival time of pig xenotransplants. PCMV has been identified as a significant factor in reducing transplant survival by disrupting the coagulation system and suppressing the immune system in non-human primates. This highlights the necessity of eliminating PCMV from donor pigs to enhance the success of xenotransplantation (Denner, 2018). The advancements in genetic modifications using CRISPR/Cas9 technology pave the way for more successful xenotransplantation by reducing the risk of immunological rejection. This technology allows for precise and efficient editing of the porcine genome, which is crucial for making pig organs more compatible with human
RkJQdWJsaXNoZXIy MjQ4ODY0NQ==